Public procurement notice: Contract Notice
Published: 2016-07-20
Buyer: Institute for lung diseases and TB
Country: MK
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33000000
Estimated value: 5 MKD
Submission deadline: 2016-08-08
Award criteria: Lowest price

Technical requirements: Purchase of drugs given orally or intravenously and intramuscularly for the Institute for Lung Diseases and TB Skopje.
1. That in the past 5 years has been determined effective decision for participation in criminal organization, corruption, fraud or money laundering;
2. Has been determined secondary penalty for suspension for participation in Public Calls, for awarding Public Procurement Contracts and for awarding Public Private Partnership Contracts;
3. Has been determined secondary penalty for temporary or permanent suspension for execution of other activity;
5. That has unpaid taxes, fees and other public duties, except if economic operator has been approved delayed payment of taxes, fees and other public duties in accordance with special regulations and if economic operator regularly pays them;
6. That has been determined criminal sanction — prohibition for professional execution, activity or duty, or temporary prohibition for execution of temporary activity, and
8. The economic operator shall submit a document concerning its registered activity (a DID Form), or evidence that it is a member of an appropriate professional association in its country of registration.
9. Decision (valid) for activities wholesaling drugs and medical devices issued by ministry of health of the Republic of Macedonia/ competent authority of the country of registration of economic operator.
Offered drugs in the technical specifications of section 1 to section 71 must be approved for circulation in the country with a Decision granting approval for marketing the drug or approval for parallel import or temporary approval for parallel import license issued by the Ministry of Health of the Republic of Macedonia / medicines Agency.
Decision granting approval for marketing the drug in the territory of the Republic of Macedonia or approval for parallel import or temporary approval for parallel import license issued by the Ministry of Health of the Republic of Macedonia / Medicines Agency for the medicines of the technical specifications of section 1 to part 71.

Eligibility requirements: 1. That in the past 5 years has been determined effective decision for participation in criminal organization, corruption, fraud or money laundering; 2. Has been determined secondary penalty for suspension for participation in Public Calls, for awarding Public Procurement Contracts and for awarding Public Private Partnership Contracts; 3. Has been determined secondary penalty for temporary or permanent suspension for execution of other activity; 4. That undergoes procedure of bankruptcy or liquidation; 5. That has unpaid taxes, fees and other public duties, except if economic operator has been approved delayed payment of taxes, fees and other public duties in accordance with special regulations and if economic operator regularly pays them; 6. That has been determined criminal sanction — prohibition for professional execution, activity or duty, or temporary prohibition for execution of temporary activity, and 7. That gives false data or does not submit data that is required by contracting authority. 8. The economic operator shall submit a document concerning its registered activity (a DID Form), or evidence that it is a member of an appropriate professional association in its country of registration. 9. Decision (valid) for activities wholesaling drugs and medical devices issued by ministry of health of the Republic of Macedonia/ competent authority of the country of registration of economic operator. No. Offered drugs in the technical specifications of section 1 to section 71 must be approved for circulation in the country with a Decision granting approval for marketing the drug or approval for parallel import or temporary approval for parallel import license issued by the Ministry of Health of the Republic of Macedonia / medicines Agency. Decision granting approval for marketing the drug in the territory of the Republic of Macedonia or approval for parallel import or temporary approval for parallel import license issued by the Ministry of Health of the Republic of Macedonia / Medicines Agency for the medicines of the technical specifications of section 1 to part 71.
No.
Offered drugs in the technical specifications of section 1 to section 71 must be approved for circulation in the country with a Decision granting approval for marketing the drug or approval for parallel import or temporary approval for parallel import license issued by the Ministry of Health of the Republic of Macedonia / medicines Agency. Decision granting approval for marketing the drug in the territory of the Republic of Macedonia or approval for parallel import or temporary approval for parallel import license issued by the Ministry of Health of the Republic of Macedonia / Medicines Agency for the medicines of the technical specifications of section 1 to part 71.
Offered drugs in the technical specifications of section 1 to section 71 must be approved for circulation in the country with a Decision granting approval for marketing the drug or approval for parallel import or temporary approval for parallel import license issued by the Ministry of Health of the Republic of Macedonia / medicines Agency.
Decision granting approval for marketing the drug in the territory of the Republic of Macedonia or approval for parallel import or temporary approval for parallel import license issued by the Ministry of Health of the Republic of Macedonia / Medicines Agency for the medicines of the technical specifications of section 1 to part 71.

Award value: 5